Expertise in
8
conditions

Norio Itokawa

Tokyo, JP 
Expertise in
8
conditions
Tokyo, JP 

Overview

Norio Itokawa practices practicing medicine in Tokyo, Japan.

Mr. Itokawa is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Liver Cancer, Hepatitis C, Hepatitis, Cirrhosis, and Endoscopy.

He is actively involved in clinical research, co-authoring 193 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Tokyo, Japan
Other Locations
Inzai, Japan
Chiba, Japan
Takamatsu, Japan
Sendagi, 1138603, Japan
Sapporo, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Double-blind, Multi-dose, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of GSK2330672 Administration for the Treatment of Pruritus in Patients With Primary Biliary Cholangitis (GLIMMER: GSK2330672 triaL of IBAT Inhibition With Multidose Measurement for Evaluation of Response)
A Randomized, Double-blind, Multi-dose, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of GSK2330672 Administration for the Treatment of Pruritus in Patients With Primary Biliary Cholangitis (GLIMMER: GSK2330672 triaL of IBAT Inhibition With Multidose Measurement for Evaluation of Response)
Enrollment Status: Completed
Publish Date: May 04, 2021
Intervention Type: Drug
Study Phase: Phase 2

193 Total Publications

Simplified BALAD (BALAD-S) Score as a Guide for First-Line Immune Checkpoint Inhibitor Selection for Unresectable Hepatocellular Carcinoma.
Simplified BALAD (BALAD-S) Score as a Guide for First-Line Immune Checkpoint Inhibitor Selection for Unresectable Hepatocellular Carcinoma.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: May 29, 2026

Frequently Asked Questions about Norio Itokawa

Is Norio Itokawa a top-rated expert for Liver Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Norio Itokawa is classified as an Distinguished expert for Liver Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Norio Itokawa participate in research or clinical trials?

Yes. Norio Itokawa has published 193 articles and abstracts on conditions like Liver Cancer. You can view a list of Norio Itokawa's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Itokawa's expertise for a condition
ConditionClose
    View All 25 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile